李 嘉華

Medicine & Life Sciences

1. Nicotinic Receptors 100%
2. Breast Neoplasms 87%
3. Nicotine 66%
4. Neoplasms 55%
5. Apoptosis 44%
6. Neoplasm Metastasis 43%
7. Colonic Neoplasms 38%
8. Thyroid Neoplasms 37%
9. Breast 36%
10. Carcinogenesis 33%
11. Meta-Analysis 30%
12. Clustered Regularly Interspaced Short Palindromic Repeats 28%
13. Tobacco 27%
14. Carcinogens 27%
15. In Vitro Techniques 27%
16. Smoking 25%
17. Down-Regulation 25%
18. Phloretin 25%
19. Tocopherols 24%
20. Epithelial Cells 23%
21. Terbinafine 23%
22. Randomized Controlled Trials 22%
23. Proteins 22%
24. Cell Movement 20%
25. Cell Proliferation 20%
26. Anaplastic Thyroid Carcinoma 19%
27. Therapeutics 19%
28. Liver Neoplasms 18%
29. Polyphenols 18%
30. garcinol 18%
31. Estrogens 17%
32. Genes 17%
33. tubulazole 17%
34. Gene Editing 16%
35. Cell Line 16%
36. Taiwan 16%
37. lesinurad 15%
38. 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone 15%
39. Imatinib Mesylate 15%
40. Growth 15%
41. Triple Negative Breast Neoplasms 14%
42. Up-Regulation 14%
43. pterostilbene 13%
44. Squamous Cell Carcinoma of Head and Neck 13%
45. Hep G2 Cells 13%
46. Econazole 13%
47. Ferroptosis 13%
48. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12%
49. Vitamin E 12%
50. Cell Death 12%